Spotlight
Twitter feed
Last chance to view #AACR20 sessions on demand:
Presentations and posters from the two AACR Virtual Annual Meetings will remain available through Wednesday, September 30. Access is free, but registration is required.
Learn more:
https://t.co/t9ETNNva3c
Deadline: Oct 6
Fellows are invited to apply for the AACR-AstraZeneca START Grants. These three-year, $225,000 grants provide opportunity for fellows to research epigenetic or DNA damage response in cancer in both academia and industry. Apply today:
https://t.co/CFhelPK126
Windy Dean-Colomb and Lewis R. Roberts @MayoClinic will discuss "Cancer Clinical Trial Inclusion and Diversity: Challenges and Opportunities" in a session at the AACR virtual conference on Cancer Health Disparities, Oct 2-4. #AACRDisp20 @ColombDean https://t.co/we435wHuxR
Patient advocates:
Join us Thurs, Oct 1 for a Virtual Forum on #COVID19 and Cancer. Patients, scientists, and clinicians will discuss:
-Impact on cancer care and research
-Current state of COVID-19 science
-Development of COVID-19 treatments
Learn more:
https://t.co/MkKurupGqk
.@ConquerCancerFd will receive support in 2021 from @TapCancerOut, a nonprofit org intended to motivate and empower the Brazilian jiu-jitsu community to raise awareness and funds for cancer-fighting organizations #ASCOconnection
Conquer Cancer Donor Spotlight: Into the Ring With Tap Cancer Out
Conquer Cancer, the ASCO Foundation, will receive support in 2021 from Tap Cancer Out, a nonprofit organization intended to motivate and empower the B...
fal.cn
Deadline: October 5
Submit an abstract for the AACR conference on The Evolving Tumor Microenvironment in Cancer Progression, Jan 9-12, 2021.
https://t.co/O7pMMMfLDc
We are proud to be named one of the world’s best cancer hospitals by @Newsweek. In its World’s Best Specialized Hospitals 2021 rankings, @DanaFarber came in as number 3 globally & the only hospital in New England to be ranked in the top 20 for #oncology: https://t.co/lZGTog5q2v
Our @AACR_CEO explains that cancer research is critical to delivering new lifesaving treatments, including innovative molecularly targeted therapies and immunotherapies, to patients with cancer. https://t.co/aZrDPV52gk #WorldCancerResearchDay #CancerProgressReport
Research has brought tremendous progress in screening and early detection of cancer, including tests for cancers of the breast, cervix, colon, and lung. https://t.co/xWsBGdXfTD #WorldCancerResearchDay #CancerScreening
Today, @AACRPres and #AACRFellows Antoni Ribas, MD, PhD, discussed the tremendous progress being made against cancer on a special #WorldCancerResearchDay virtual panel. Learn more on the #AACRBlog: https://t.co/iYgitIqrM4
Recent publications
Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine. Clin. Cancer Res.
Traditional Diagnostics versus Disruptive Technology: The Role of the Pathologist in the Era of Liquid Biopsy. Cancer Res.
Announcements
Research
Strategic alliances
Our strategic alliances drive research innovations and lead to improved therapies to benefit cancer patients
Donor highlight
Robert and Renée Belfer’s transformative cumulative Dana-Farber investment of more than $25 million launched the Robert A. and Renée E. Belfer Center for Applied Cancer Science. Their generosity enabled the Belfer Center to integrate its scientific teams, produce innovative cancer models, partner with industry leaders, and accelerate the development of revolutionary therapies to treat cancer. We are grateful for their vision and incredible support.
